ClinicalTrials.govpublic full text
HIV Risk Reduction and Drug Abuse Treatment in Iran
opiate dependence, hiv infections, buprenorphine, naltrexone, hiv risk reduction behavior, counseling, hiv seronegativity, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 991690
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.